PubMed=6809308
Ishida R., Buchwald M.
Susceptibility of Fanconi's anemia lymphoblasts to DNA-cross-linking and alkylating agents.
Cancer Res. 42:4000-4006(1982)

PubMed=2805228; DOI=10.1093/carcin/10.11.2067
Arita I., Tachibana A., Takebe H., Tatsumi K.
Predominance of Mex+ cells in newly-established human lymphoblastoid cell lines.
Carcinogenesis 10:2067-2073(1989)

PubMed=8340107; DOI=10.1007/BF00205077
Almeida A., Kokalj-Vokac N., Lefrancois D., Viegas-Pequignot E., Jeanpierre M., Dutrillaux B., Malfoy B.
Hypomethylation of classical satellite DNA and chromosome instability in lymphoblastoid cell lines.
Hum. Genet. 91:538-546(1993)

PubMed=7987813; DOI=10.1016/0165-4608(94)90052-3
Montpellier C., Bourgeois C.A., Kokalj-Vokac N., Muleris M., Niveleau A., Reynaud C., Gibaud A., Malfoy B., Dutrillaux B.
Detection of methylcytosine-rich heterochromatin on banded chromosomes. Application to cells with various status of DNA methylation.
Cancer Genet. Cytogenet. 78:87-93(1994)

PubMed=7994019; DOI=10.1182/blood.V84.12.3995.bloodjournal84123995
Liu J.M., Buchwald M., Walsh C.E., Young N.S.
Fanconi anemia and novel strategies for therapy.
Blood 84:3995-4007(1994)